Search

Your search keyword '"Vanesa Royo"' showing total 3 results
Start Over Author "Vanesa Royo"
3 results on '"Vanesa Royo"'

1. 50 - IDENTIFICACIÓN DE BIOMARCADORES DIAGNÓSTICOS DE LA ENFERMEDAD INFLAMATORIA INTESTINAL EN SUERO Y ORINA MEDIANTE UN ABORDAJE PROTEÓMICO

Author

Montse Baldán-Martín, Mikel Azkargorta, Ibon Iloro, Irene Soleto, Macarena Orejudo, Cristina Ramirez, Jorge Mercado, Sabino Riestra, Montserrat Rivero, Ana Gutiérrez, Iago Rodríguez-Lago, Luis Fernández-Salazar, Daniel Ceballos, José Manuel Benítez, Mariam Aguas, Iria Bastón-Rey, Fernando Bermejo, María José Casanova, Rufo Lorente, Yolanda Ber, Vanesa Royo, María Esteve, Félix Elortza, Javier P. Gisbert, and María Chaparro

Subjects
Hepatology, Gastroenterology
Published
2023
Full Text
View/download PDF

2. 66 - EL ANÁLISIS DEL TEJIDO INTESTINAL DE PACIENTES RECIÉN DIAGNOSTICADOS DE ENFERMEDAD INFLAMATORIA INTESTINAL REVELA PERFILES PROTEÓMICOS ESPECÍFICOS

Author

Montse Baldán-Martín, Ibon Iloro, Mikel Azkargorta, Cristina Ramirez, Irene Soleto, Macarena Orejudo, Jorge Mercado, Carlos H. Gordillo, Sabino Riestra, Montserrat Rivero, Ana Gutiérrez, Iago Rodríguez-Lago, Luis Fernández-Salazar, Daniel Ceballos, José Manuel Benítez, Mariam Aguas, Iria Bastón-Rey, Fernando Bermejo, María José Casanova, Rufo Lorente, Yolanda Ber, Vanesa Royo, María Esteve, Félix Elortza, Javier P. Gisbert, and María Chaparro

Subjects
Hepatology, Gastroenterology
Published
2023
Full Text
View/download PDF

3. [Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis]

Author

Andrés, Sansó Sureda, Vicenç, Rocamora Durán, Amparo, Sapiña Camaró, Vanesa, Royo Escosa, and María José, Bosque López

Subjects
Adult, Interleukin-12 Subunit p40, Tumor Necrosis Factor-alpha, Adalimumab, Antibodies, Monoclonal, Phototherapy, Antibodies, Monoclonal, Humanized, Combined Modality Therapy, Infliximab, Crohn Disease, Adrenal Cortex Hormones, Azathioprine, Humans, Psoriasis, Drug Therapy, Combination, Female, Ustekinumab, Drug Eruptions, Mesalamine, Immunosuppressive Agents
Abstract

Treatment with anti-tumor necrosis factor (TNF)-α for Crohn's disease is relatively safe, although various cutaneous adverse effects have been reported such as the development or exacerbation of anti-TNF- α-induced psoriasis, which can sometimes lead to treatment withdrawal. Therefore, new alternative treatments with new mechanisms of action are required. Ustekinumab, a monoclonal antibody against the p40 subunit of interleukin 12/23, could induce response in patients with Crohn's disease and has demonstrated efficacy in patients with psoriasis. We present the case of a woman with Crohn's disease who developed psoriasis after treatment with two anti-TNF- α drugs (infliximab and adalimumab). The patient was subsequently treated with ustekinumab with resolution or psoriasis lesions and maintenance of remission of Crohn's disease.

Published
2011

Catalog

Books, media, physical & digital resources
See catalog results